Jay Rughani Profile Banner
Jay Rughani Profile
Jay Rughani

@JayRughani

Followers
4,422
Following
930
Media
132
Statuses
1,600

Partner @a16z investing in health & bio software. Prev @flatironhealth (acq by @roche for ~$2b) & @deloittehealth . Professional student.

SF+NYC
Joined June 2011
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@JayRughani
Jay Rughani
8 months
Where do we most need AI in healthcare? To outline the most viable use cases for AI in healthcare today, we @a16z interviewed many of the largest healthcare orgs across the country. Here are the 19 areas we prioritized:
Tweet media one
21
104
491
@JayRughani
Jay Rughani
2 years
How can you get your healthtech product to market faster? One increasingly popular way is B2C2B, or selling directly to end users before the enterprise. @julesyoo & I explore how in the 1st of a 5-part series on GTM in digital health by the @a16z team:
7
31
199
@JayRughani
Jay Rughani
1 year
Science needs better Software. The good news: waves of talented builders are jumping in to help, enabling biotech to further accelerate how drugs are Discovered + Developed + Distributed. @JorgeCondeBio & I "sketch out" Biotech’s Tech moment:
10
24
181
@JayRughani
Jay Rughani
3 months
a16z at The White House 🇺🇸
Tweet media one
6
1
158
@JayRughani
Jay Rughani
5 months
Introducing Inductive Bio: an AI company that enables scientists to accelerate new medicine optimization. Founded by Josh Haimson + Ben Birnbaum with whom we are thrilled to be working together again! They previously launched/led ML at Flatiron Health, where we first teamed up:)
Tweet media one
7
5
144
@JayRughani
Jay Rughani
2 years
Health-tech friends building in NYC 🗽. Thanks for hanging with @daisydwolf & me last night. More dinners to come!
Tweet media one
6
3
138
@JayRughani
Jay Rughani
2 years
How can you better connect our healthcare system through software? One increasingly promising way is to take a multi-sided network strategy. @vintweeta & I explore *how* with 5 iconic founders in this episode of GTM in digital health by the @a16z team:
6
22
110
@JayRughani
Jay Rughani
5 years
Who pays for your prescription drugs? Interesting graphic on the flows between drugmaker <> wholesaler <> pharmacy <> PBM <> insurer... and the consumer from @lydiaramsey125 @skyegould @businessinsider
Tweet media one
6
20
85
@JayRughani
Jay Rughani
4 years
This is literally a map of new startup ideas in healthcare. These were already worthwhile problems to solve in January... now experiencing once-in-a-generation tailwinds! It's time to build in healthcare.
@julesyoo
Julie Yoo
4 years
1/ We’re living thru The Great Unlock in healthcare - things we thought would take 10+ yrs to play out are now playing out in 2-3. Massive dislocation is changing the very topology of the industry, enabling tech to be wedged into zones that were historically intractable.
Tweet media one
7
66
315
0
18
80
@JayRughani
Jay Rughani
1 year
What can healthtech founders learn from the most favored public companies? Beyond growth & profitability, there’s one trait they share: business model “magic.” Check out the latest @a16z piece from me, @julesyoo , @skupor , & @mmehta17 for how to amplify it in your business.(1/3)
Tweet media one
3
12
77
@JayRughani
Jay Rughani
3 years
1/ Scientists need better software tools! 🔬⚡️💻 That’s why @jorgecondebio & I are excited to announce that @a16z is leading @biodockai ’s seed financing: founders @MichaelLee04 & @nurlybek_m are building the modern operating system for biological data analysis.
4
9
73
@JayRughani
Jay Rughani
2 years
1/ Oncologists should have the best possible tools to select treatments for their patients. @Valarlabs is building the AI-enabled data interpretation platform for cancer care. @vintweeta & I are excited to share that @a16z is leading their seed round!
4
15
64
@JayRughani
Jay Rughani
2 years
The @a16z Bio+Health team has the privilege of supporting bold entrepreneurs building across life sciences & care delivery. With our new $1.5B bio+health & $5B growth funds, we're continuing to invest at pre-seed, seed, series A, series B, & beyond.
2
2
61
@JayRughani
Jay Rughani
2 years
Paying for the $4T healthcare we consume requires better fintech infrastructure, data connectivity, & software tools. @mandrusko1 @dhaber @daisydwolf @julesyoo outline many of the opportunities we're watching @a16z :
Tweet media one
@julesyoo
Julie Yoo
2 years
1/ The intersection of Healthcare x Fintech = a meaty zone in which to build. But where to start? What makes for a good play? What learnings from general fintech apply? Some thoughts from Team @a16z Healthcare x Fintech:
Tweet media one
10
50
224
1
4
59
@JayRughani
Jay Rughani
6 months
The US healthcare system is on an unsustainable trajectory. Our healthcare providers experience increasing burnout, our health systems face growing labor shortages, and our economy shoulders ballooning healthcare costs. Yet our clinicians are being asked to do more with less:…
7
12
58
@JayRughani
Jay Rughani
9 months
Exciting milestone for Thyme Care: Series B to support many more cancer patients in their care journeys. Welcome to new partners @townhallvntrs and @ForesiteCapital and congrats to the @ThymeCares team!
Tweet media one
3
2
54
@JayRughani
Jay Rughani
2 years
Three Fintech x Healthtech intersection opportunities highlighted by @julesyoo & @dhaber : 1⃣ consumer payments & lending 2⃣ provider practice enablement 3⃣ unbundling & re-bundling insurance Hit us @a16z up if you're building at this intersection!
@dhaber
David Haber
2 years
. @julesyoo and I are very excited about the intersection of Fintech x Healthcare: "As fintech makes its way into healthcare services and software, we see the potential to rewire incentives and remove inefficiencies to pave the way for a more value-oriented healthcare system."
Tweet media one
9
7
72
3
3
46
@JayRughani
Jay Rughani
3 years
Tweet media one
6
16
43
@JayRughani
Jay Rughani
11 months
Fun evening with this AI x Health crew for #SFTechWeek
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
4
40
@JayRughani
Jay Rughani
5 months
AI is changing the economics of healthcare. Today, most healthcare companies are not set up to operate efficiently. Consider that publicly traded healthcare companies (excluding pharma) generate $2.6T in revenue and yet turn only ~10% of that revenue into profit. Even more…
Tweet media one
3
3
38
@JayRughani
Jay Rughani
4 months
We live in amazing times: novel medicines are increasingly available for once-untreatable conditions. Yet, our current healthcare delivery and insurance system is not designed for us to purchase and distribute these innovative therapies at scale.
Tweet media one
2
2
38
@JayRughani
Jay Rughani
3 years
Funniest thing I read today on my flight to #HLTH2021 @healthbjk interview by @nikillinit , covering EHR data access, HL7, FHIR, new ONC interop rules, data highways, & of course, Verona, WI.
Tweet media one
0
3
38
@JayRughani
Jay Rughani
9 months
Capability != economics for AI startups historically, but there’s an increasingly strong economic case for generative AI products across verticals (incl. healthcare!!) @martin_casado at @a16z ’s AIR today in SF
1
17
35
@JayRughani
Jay Rughani
3 years
Every cancer patient deserves a trusted companion guiding them to the highest-value care at each step of their journey. @a16z is thrilled to support @ThymeCares in making that happen. @vintweeta explains perfectly why the "time for Thyme Care is now"!
1
4
36
@JayRughani
Jay Rughani
7 months
Awesome AI use case. Now do a medical bill...
@petergyang
Peter Yang
7 months
I will never get a parking ticket again.
Tweet media one
403
2K
25K
1
2
36
@JayRughani
Jay Rughani
4 years
Out of stealth: Scribe Therapeutics launches its platform for engineering CRISPR-based genome editing medicines, as well as a $400M+ collaboration with Biogen ✂️✍️💉 Congrats to @BenjaminLOakes , @doudna_lab & the Scribe team.
@vijaypande
Vijay Pande
4 years
14/ Scribe represents a major shift in therapeutics, from a discovery approach to an industrialized means to design treatments that address a large class of diseases – allowing for the rapid development of novel therapeutics to improve the lives of millions of people worldwide.
2
4
16
0
4
35
@JayRughani
Jay Rughani
1 year
Next chapter of our @a16z healthtech GTM series is about selling through channel partners—PBMs, EHRs, GPOs, TPAs, Plans, etc. If your startup does this, we'd love to hear your perspective and potentially feature you in the blog! Just fill this survey out:
0
3
31
@JayRughani
Jay Rughani
2 years
Healthcare biz model nerds 📢 come help us find & pick the next iconic health tech company to support @a16z .
@julesyoo
Julie Yoo
2 years
Are you a healthcare biz model nerd? Get a kick out of Health Affairs articles and digital health 10-Ks? Psyched about the future of virtual-first value-based care? Come be a Healthcare Deal Analyst on Team @a16z bio+health
4
23
122
1
2
33
@JayRughani
Jay Rughani
2 years
NYC
Tweet media one
Tweet media two
0
1
32
@JayRughani
Jay Rughani
2 years
As we @a16z continue studying GTM motions in healthtech, we would love to hear what has worked for your team. DMs open! We'll continue posting our learnings on this hub page: @julesyoo @vintweeta @vijaypande @JorgeCondeBio @justin_larkinMD @daisydwolf
1
2
32
@JayRughani
Jay Rughani
1 year
How can you distribute your healthtech product more broadly? One way is by selling through channel partners.  @julesyoo , @annie_m_collins , & I explore how in our next GTM piece by the @a16z team:
2
6
32
@JayRughani
Jay Rughani
3 years
Bio platforms are more productive than ever. But with broader applicability comes great responsibility🕷️: How to explore all the good your tech can do, with only the finite resources of a startup? One way: TEAM UP. @JorgeCondeBio & I offer tips on how.🚀
2
12
33
@JayRughani
Jay Rughani
3 years
After 30 years of trial and error, I still essentially have no idea how different foods affect my long-term health. I don't think I'm alone in that, which is why I'm so inspired by the vision of the @Levels team
@vijaypande
Vijay Pande
3 years
1/ @Jeff_Jordan and I are excited to announce that @a16z is leading @Levels $12M Seed Round to bring biowearables into the mainstream and improve metabolic health.
22
49
592
2
3
32
@JayRughani
Jay Rughani
3 years
1/ My favorite behind the scenes, cutting room floor gem from @a16z ’s Bio Eats World podcast yesterday with Dr. Freda Lewis-Hall—the changing perception around partnerships in the biopharma industry since she joined it in 1994:
1
4
31
@JayRughani
Jay Rughani
2 years
"There are no more worthwhile endeavors than our most brilliant minds taking great risks to improve the world by doing something larger than themselves." Excited to team up with those building the future 🙌
@vijaypande
Vijay Pande
2 years
1/ I’m thrilled to announce our fourth @a16z Bio Fund, bringing $1.5B of new capital to invest in the intersection of technology, life sciences & healthcare.
39
95
899
3
0
32
@JayRughani
Jay Rughani
2 years
Consumer healthtech builders -- come learn with us! @daisydwolf & the rest of the @a16z Bio+Health team are arranging conversations to explore open opportunities to help consumers live happier & healthier lives🙂
@daisydwolf
Daisy Wolf
2 years
📣 Calling all consumer health builders! 📣 We @a16z are planning events – fireside chats, dinners, & more – to bring together experts & smart folks in the space. Some virtual & some in person (NYC & SF to start). Interested in joining? Fill out this form!
3
24
117
1
1
30
@JayRughani
Jay Rughani
1 year
AI reading list 📖📚👀
@a16z
a16z
1 year
Research in artificial intelligence is increasing at an exponential rate. Even experts struggle to keep up with everything new. So we've curated a list of 3rd-party resources we’ve relied on to get smarter about modern AI, that we're calling "AI Canon." 👇
44
109
379
2
4
30
@JayRughani
Jay Rughani
1 year
What is more valuable than our health? My @a16z partners @vijaypande @daisydwolf start off #HLTH2022 with a bold prediction: the most valuable company in the world will be a consumer health tech company.
@vijaypande
Vijay Pande
1 year
1/We think the biggest company in the world will be a consumer health tech company. Four of the top five biggest companies in the world are consumer companies, and healthcare is one of the nation’s biggest industries. @daisydwolf @a16z @a16zBioHealth
66
164
902
2
6
30
@JayRughani
Jay Rughani
2 years
healthcare is literally the last market to move from fee-for-service to value-based-care. also, these rates for exec search are crazy.
@martin_casado
martin_casado
2 years
A trend from exec search firms to be aware of -- more and more they're asking for equity as part of the search, and burying it deep in the docs. .08 to .1 is not unusual. Which is totally crazy. Be sure to run the math before agreeing to something like this!
23
8
106
1
0
30
@JayRughani
Jay Rughani
3 years
My parents lost a son due to complications related to sepsis on Sep 12, 1985 before I was born. Sadly, too many families have stories like this. So I'm particularly inspired by the results of @bayesianhealth 's prospective study on their early warning system for sepsis:
Tweet media one
2
1
30
@JayRughani
Jay Rughani
1 year
Areas of opportunity in consumer health from my @a16z colleagues @daisydwolf + @julesyoo 🔎👇
@daisydwolf
Daisy Wolf
1 year
1/ Last month, @vijaypande and I predicted a consumer health company will be the biggest company in the world (‼️). This invoked lots of **feelings** 🤯. This month, @julesyoo and I dive into specific areas of consumer health where we see opportunity. A 🧵:
15
28
180
2
5
28
@JayRughani
Jay Rughani
1 year
What's more important than our health? If you are looking for an intimidating, regulated, complex, but mission critical problem to solve: come to healthcare!
@vijaypande
Vijay Pande
1 year
Hey Tech, It’s Time To Build. In Healthcare. In the past few months, the founders of Instacart, Spotify, and Coinbase have all started new healthcare companies. Why are these seasoned tech founders jumping into tech-driven healthcare? 1/
20
40
239
1
1
30
@JayRughani
Jay Rughani
3 years
Patients deserve transparent prices for the care they need. 🏥💲 New common-sense regulations are finally unlocking access to prices for all.⚖️🔓 @TurquoiseHC is building a provider-payer marketplace to enable fair competition in favor of empowered consumers of healthcare.🙌⚡️
3
7
29
@JayRughani
Jay Rughani
3 years
Bezos 2018 letter puts experiments like Haven into context. I'm excited for the new healthcare products that will be built on the hard-earned learnings from this experiment.
Tweet media one
1
2
30
@JayRughani
Jay Rughani
2 years
Brilliant & optimistic teams are building at the intersection of biology & computer science to advance human health. @endpts profiled how @vijaypande @JorgeCondeBio @vintweeta @julesyoo & the @a16z Bio+Health crew have been expanding our efforts to support those teams.
@vijaypande
Vijay Pande
2 years
We believe our society is poised to benefit greatly from the next major tech revolution — this time in the biotech space. Thanks @endpts for sharing the story of @a16z ’s journey into bio as well as my own path from academia to VC.
12
19
132
0
0
29
@JayRughani
Jay Rughani
3 years
We call it a healthcare "system", but to a patient leaving a doctor's office, it can often feel like you're on your own.🤒 Thankfully @memorahealth is building the modern OS for healthcare, connecting silos of care into a continuous, proactive, & intuitive care experience.⚡️📱😀
@memorahealth
Memora Health
3 years
1/ Today, we’re excited to announce a $10.5M financing led @a16z ! Memora Health is building an operating system to help modernize how our largest healthcare organizations deliver care.
6
25
119
0
1
29
@JayRughani
Jay Rughani
11 months
All my UK uncles & aunties asking me when I'm moving back to London 👀🇬🇧
@RishiSunak
Rishi Sunak
11 months
Great news that @a16z – one of the world’s leading tech investment firms, is opening a new base here in London. Another huge vote of confidence in the UK as a place to build and grow tech businesses of the future.
Tweet media one
776
856
6K
1
0
28
@JayRughani
Jay Rughani
9 months
The hardest problems in AI are in bridging the worlds of bits and atoms. @DaphneKoller sharing why she committed to building an AI company in the life sciences: to deliver better medicines to people who need them. At @a16z AIR in conversation w/ @vijaypande
Tweet media one
0
2
28
@JayRughani
Jay Rughani
2 years
Developing more life-saving medicines requires expanding our clinical trial infrastructure. 🏗️🔬🧬 Topography is activating new capacity by empowering clinicians to conduct A+ research at their practices.🛠️💻🏥 @julesyoo articulates why we @a16z are so excited to support! 🙌
@julesyoo
Julie Yoo
2 years
0/ Among the many mighty healthcare supply-demand mismatch problems, one of the most vexing is the low % of physicians participating in clinical trials, while most trials enroll insufficient patients, let alone a diverse enough set of patients representative of the population.
Tweet media one
6
15
42
2
0
26
@JayRughani
Jay Rughani
4 years
Welcome to @a16z @vintweeta ...excited to work together again!!
@a16z
a16z
4 years
Vineeta Agarwala @vintweeta , our newest general partner:
1
7
59
0
2
27
@JayRughani
Jay Rughani
1 year
Fun hosting this AI x health crew w/ @daisydwolf + @ARSaporta
@daisydwolf
Daisy Wolf
1 year
Had the best night hanging with this AI x health crew🗽
Tweet media one
4
3
87
2
0
27
@JayRughani
Jay Rughani
7 months
How are healthcare leaders evaluating & deploying AI solutions today? We @a16z interviewed many of the largest healthcare orgs to highlight how their eval criteria for AI solutions might inform how entrepreneurs bring their products to market.
Tweet media one
1
11
26
@JayRughani
Jay Rughani
2 years
Software x biotech builder community in NYC 🗽 is strong 🙌 Look what you've created @nlarusstone @bitsinbio . Thanks for bringing us together yesterday @apoorvasriniva @tjbollerman 🙏
@bitsinbio
Bits in Bio
2 years
NYC BiB meetup went well!
Tweet media one
0
1
27
1
1
24
@JayRughani
Jay Rughani
3 years
"We are dedicated to offering the best platform to bring companies from seed through IPO" 🌱🌱🌱
@a16z
a16z
3 years
We’re excited to announce our $400M seed fund. Seed has always been a core part of our strategy. This fund underscores our commitment to founders on this leg of the journey and to seed investing as first class motion for the firm.
61
256
2K
0
0
25
@JayRughani
Jay Rughani
2 years
Benchmarking the cash you burn for every $1M of net ARR you add can help you understand the efficiency of your growth -- regardless of the market environment. To compare, here are burn multiples by stage analyzed by @DavidGeorge83 , @justin_kahl , & our @a16z growth team:
Tweet media one
2
1
23
@JayRughani
Jay Rughani
1 year
Paying for healthcare is painful, but it shouldn't be. Thatch Health is on a mission to fix it, both for employers & employees. @julesyoo & I @a16z are thrilled to be partnering with Chris, Adam, & the entire @thatch_ai team on simplifying the healthcare financial experience.🧵
Tweet media one
4
2
23
@JayRughani
Jay Rughani
2 years
Last week at the J&J Data Science & Digital Health Symposium, I enjoyed discussing how integrated cloud systems of record + data flows from virtual-first care delivery rails can together unlock R&D throughput.
Tweet media one
1
0
23
@JayRughani
Jay Rughani
2 years
Build the modern biotech software stack @OctantBio … also you get to refer to yourself as an “Octonaut”, so what else do you need really?
@OctantBio
Octant Bio
2 years
New year, new job?! We are hitting the ground running in 2022, building and scaling Octant’s Software team with our 2nd, 3rd, and 4th team hires. It's a good time to consider a career as an Octonaut! Check out:
0
6
16
0
0
24
@JayRughani
Jay Rughani
3 years
I skipped my coffee this morning and instead listened to this convo w. @Jonathan_Bush & @julesyoo . Woke me right up 🙂
@a16z
a16z
3 years
Github for healthtech? @Jonathan_Bush of Zus Health joins @julesyoo on Bio Eats World to talk about the history and future of infusing tech with healthcare.
1
9
37
0
1
24
@JayRughani
Jay Rughani
4 months
Today, I'm excited to discuss the opportunities for AI to enable 10x better experiences, economics, and outcomes of healthcare at #jpm2024 with John Rootenberg, MD @Roche , Steve Mutkoski @Microsoft , Megan Callahan at Welsh Carson, and our hosts Alya Sulaiman + Anirudh Goel at the…
1
1
23
@JayRughani
Jay Rughani
3 years
"Genomics is currently a laboratory testing-based industry, but in the future it will look very much like an information industry" Sean George, Invitae CEO Congrats to @ciitizen + @Invitae teams on joining forces to empower patients with their combined genomic + clinical data
@ciitizen
Ciitizen
3 years
We are thrilled to announce that Ciitizen and @Invitae are joining forces to advance the future of empowering patient control of their medical data. Click here to read the full statement from our founder @anilsethiusa :
0
13
62
0
2
23
@JayRughani
Jay Rughani
4 years
Biology is hard. BUT - when you're lucky enough to be around pioneers like @srikosuri @rhomsany - it's hard not to be optimistic about humanity's ability to deal w/ whichever disease nature throws at us. 📖💻🔬💥
@srikosuri
Sri Kosuri
4 years
Really excited to be building @OctantBio w/ @a16z and having @JorgeCondeBio and @vijaypande join us. It is indeed time to build!
39
32
328
1
2
23
@JayRughani
Jay Rughani
11 months
"Every scientist will have an AI assistant/collaborator/partner that will greatly expand their scope of scientific research and achievement. Every artist, every engineer, every businessperson, every doctor, every caregiver will have the same in their worlds."...if we allow it.
@pmarca
Marc Andreessen 🇺🇸
11 months
Why AI Will Save The World -- my new megapost on why you should be excited, not scared, about AI. Enjoy!
808
598
2K
2
1
23
@JayRughani
Jay Rughani
3 years
My fam @websun23 , @ArifNathooMD & the entire @KomodoHealth all-star team accelerating their vision to *learn* from every single interaction in our healthcare system 🔥🔥🔥
@websun23
Web Sun
3 years
Thrilled to announce we’ve closed our #SeriesE round led by Tiger Global and joined by @cascapital . Get ready: we are extending our 7-year lead, executing on our vision to transform healthcare, and accelerating our market impact. 🚀
1
2
41
1
1
22
@JayRughani
Jay Rughani
2 years
"We do it for the team" is an @a16z core value & also @sarahdingwang 's middle name. 1 of my fondest memories @a16z is my 1st deal team, when I got to work w her (& @julesyoo + @JorgeCondeBio !). Sarah is the ultimate teammate, & I continue to learn so much from her.🤩 Go Sarah!
@DavidGeorge83
David George
2 years
Some very exciting  @a16z news today. I’m thrilled to announce that we’ve promoted @sarahdingwang to General Partner for the Growth Fund. More below on why…and welcome Sarah to this new role, I’m proud to call you my partner!
40
26
509
1
0
21
@JayRughani
Jay Rughani
5 years
Big news @a16z this week - my colleague @julesyoo promoted to GP. I’ve already learned a ton from her over the last year and am excited for all the work we’ll do together supporting healthcare software entrepreneurs in the future!
1
3
21
@JayRughani
Jay Rughani
2 years
Exciting day @ThymeCares : Dr. Brad Diephuis joins as CBO. Looking fwd to partnering w/ @bjdiephuis as he brings his learnings as a physician, CMS policymaker, entrepreneur, engineer, & cancer survivor to Thyme. Congrats to @rsboon , @pbcancerdoc , & entire TC team! @vintweeta
@ThymeCares
Thyme Care
2 years
Meet our new Chief Business Officer, Dr. @bjdiephuis . The former CMMI advisor will oversee Thyme Care’s business strategy and push forward our mission to change the value-based oncology care landscape. We are incredibly excited to welcome him to the team.
0
4
11
0
2
20
@JayRughani
Jay Rughani
2 years
. @a16z in the ☁️! (+ SF + NYC + LA + MIA +...)
@bhorowitz
benahorowitz.eth
2 years
We're moving! @a16z
65
88
720
0
0
17
@JayRughani
Jay Rughani
2 years
‼️ Biotech builders --> How do you best navigate the 3 acts of executing a biotech BD deal? ‼️ 🧭🗺️🔬 My brilliant @a16z colleagues @beckypferdehirt & @JorgeCondeBio offer a guide, from their experiences in the biotech BD trenches.
@beckypferdehirt
Becky Pferdehirt
2 years
1/ Business development is essential for many biotech startups, but there’s a wide chasm between wanting to partner and signing on the dotted line. @JorgeConde and I offer a beginners recipe book for the sausage making of a biotech BD deal
10
77
423
1
0
20
@JayRughani
Jay Rughani
3 years
Mental healthcare should be accessible to everyone. Grateful to the @try_headway team for leading that future through a software platform connecting patients + therapists + insurers. And glad @a16z has the opportunity to support.
@andrewlangadams
Andrew
3 years
Thrilled that @try_headway has launched in 11 states & raised a Series B led by @skupor at @a16z We're looking for great people to join us in our mission of rewiring mental healthcare for access and affordability. See roles here !
2
5
34
0
0
18
@JayRughani
Jay Rughani
2 years
Where are network effects possible in healthcare? My holiday reading to find out, thanks to ⁦ @andrewchen ⁩!
Tweet media one
0
0
19
@JayRughani
Jay Rughani
8 months
Exciting partnership announced today between Walgreens and Pearl Health
@PearlHealth_
Pearl Health
8 months
@PearlHealth_ has partnered with @Walgreens to expand access to high-quality, value-based care. We’re excited to work with the Walgreens team to enable primary care providers to deliver proactive, whole-person care in the communities they serve.
1
0
4
0
0
18
@JayRughani
Jay Rughani
2 years
We want modern healthcare experiences. @memorahealth is empowering leading healthcare organizations with the modern digital health tech stack. Excited to see all that @mnvsevak & the Memora team will build with the added fuel!
@vintweeta
Vineeta Agarwala
2 years
Congrats to the @memorahealth team on closing a latest $40m financing to fuel a next chapter of growth 🙌🏼 We @a16z led prior seed round; thrilled to continue backing @mnvsevak + team as they bring smart automation at scale to our largest healthcare orgs!
3
8
60
0
1
17
@JayRughani
Jay Rughani
3 years
2/ Today, highly-trained drug researchers spend hours analyzing microscope images - essentially one by one. It’s a painfully repetitive process that creates bias & error. @Biodockai ’s AI software platform automates months of image analysis in minutes.
2
3
18
@JayRughani
Jay Rughani
5 years
Just re-read one of my favorite @firstround articles. Great insights on how to grow teams through times of rapid scaling.
1
5
18
@JayRughani
Jay Rughani
2 years
If you would like to attend the next one, join the @bitsinbio slack community👇🏽. Meetups in Boston, DC, LA, London, NYC, SD, SF, & more. CC: @nlarusstone
2
3
17
@JayRughani
Jay Rughani
3 years
Simplifying care...at home!🏠🦽🙏 Congrats to @vjkedar & the @TomorrowHealth1 + @GeisingerHealth teams on launching this partnership to get patients the medical equipment they need.
@vjkedar
Vijay Kedar
3 years
I am excited to announce our partnership with @GeisingerHealth . @TomorrowHealth1 is thrilled to be working work with patients, physicians, and medical suppliers to improve home healthcare for over half a million GHP members.
0
3
24
0
0
18
@JayRughani
Jay Rughani
8 months
In the coming weeks, we’ll be releasing our interviews with these healthcare leaders, as well as some GTM tactics on pricing, packaging, & defensibility for AI products. For the full post, check out: @daisydwolf , @vijaypande , @julesyoo , @a16zBioHealth
0
2
17
@JayRughani
Jay Rughani
6 years
My first week @a16z
Tweet media one
4
2
16
@JayRughani
Jay Rughani
3 years
@julesyoo
Julie Yoo
3 years
Active week for @a16z healthcare portfolio! 1/ Congrats to @jdesai01 and the whole @PatientPing team for a great milestone along their path to building the definitive operating system for care transitions!
2
10
82
0
2
16
@JayRughani
Jay Rughani
5 years
"We are entering a brave new world of curative, permanent, and record-breakingly expensive therapies" - @JorgeCondeBio on the mindset shifts needed for valuing cures, and potential financial & regulatory frameworks to distribute those cures broadly
1
2
16
@JayRughani
Jay Rughani
2 years
Great feature for early startup employees. Reducing friction of 83(b) process so more people can get access to potential tax advantage.
@cartainc
Carta
2 years
Introducing: end-to-end 83(b) filing. Save time and money on the cumbersome early exercise process. Employees can now complete and submit the required form through Carta. We’ll send it to the IRS so they don’t have to.
0
2
19
0
1
16
@JayRughani
Jay Rughani
1 year
Better saas + fintech tools for care delivery! @PearlHealth_ 's provider enablement software & specialty risk marketplace empowers PCPs to deliver higher quality care at a lower cost in collaboration with financially-aligned specialty care networks. @a16z
Tweet media one
2
0
16
@JayRughani
Jay Rughani
5 years
New investment oppys potentially enabled by vertical integration (eg CVS+Aetna), real-world data availability, regulations (eg ACA), new tx modalities (eg cell & gene tx), and possible payment reform w/ @davidfaber , Ali Satvat, @JorgeCondeBio , & @porszag #HealthyReturns
Tweet media one
0
7
15
@JayRughani
Jay Rughani
2 years
How do you set up risk-based contracts for your healthtech offering? In 📢 episode 2 📢 of the @a16z GTM in digital health playbook series, @justin_larkinMD @julesyoo explore how the best builders navigate the spectrum of risk. ⚡️↔️⚡️ Highlights 👇
@justin_larkinMD
Justin Larkin, MD
2 years
What's all the hype about value based care and "going at risk" in digital health? 🚨 Second chapter of our @a16z GTM Playbooks for Digital Health is out! @julesyoo and I dig in with builders on key questions every founder should consider: 👇
1
11
74
1
1
15
@JayRughani
Jay Rughani
2 years
Who will build the health data infrastructure with which we can properly arbitrate outcomes-based payment contracts for this exciting wave of gene therapies? @DusetzinaS @VUHealthPol puts the data problem (& opportunity for startups!) well:
Tweet media one
@JorgeCondeBio
Jorge Conde
2 years
Gene therapies offer long-term cures w/ a single treatment. But they’re very expensive. How do we pay for them? Outcomes-based pricing: spread upfront cost over several years; discount if therapy stops working. “The benefit is worth the risk.” 💰🧬
1
1
14
1
1
16
@JayRughani
Jay Rughani
6 years
When your employer is mentioned on @CNBC and your proud parents text you a recording...🤷🏻‍♂️ @flatironhealth
0
0
15
@JayRughani
Jay Rughani
1 year
. @Benchling ’s Founder & CEO @sajithw sat down with me to explore how Biotech can accelerate new medicine research & development with the latest software tools Tech has to offer. Check out our convo at a recent industry meeting with biopharma leaders 👇
0
4
16
@JayRughani
Jay Rughani
3 years
“If we learn nothing else from this tragedy, we learn that life is short and there is no time for hate.” — Sandy Dahl, wife of Flight 93 pilot Jason Dahl.
0
1
16
@JayRughani
Jay Rughani
3 years
Truth from @enfeinberg 👇 It's a mistake to underestimate how good Pharma is at making new medicines. AI can help, but the art is bringing the best of both domains. I'm excited to watch the Genesis team lead the way through the noise.
@vintweeta
Vineeta Agarwala
3 years
"They don’t have patience for nebulous claims. They want to see data, lab experiments verifying computational predictions, being useful for real drug targets, otherwise it's just not interesting” @enfeinberg on value of biotech veterans working hand-in-hand w software teams 👏
3
0
23
2
0
14
@JayRughani
Jay Rughani
1 year
Thank you to the entrepreneurs who shared their inspiring ambitions to solve big problems in our global healthcare system. & thank you to my accomplished fellow judges @stacyamityfeld @julian_eison @ryu_alison for including me, & to @JNJInnovation + @HLTHEVENT for hosting us.
@JNJInnovation
Johnson & Johnson Innovation
1 year
At #HLTH2022 Startup Pitch Competition, @stacyamityfeld joined the judging panel with @JayRughani @a16z , @julian_eison @nextventuresvc , @ryu_alison @ablepartnersnyc , and shared thoughts on novel ideas from industry disruptors. Stay tuned for the winner announcement!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
3
10
0
1
14
@JayRughani
Jay Rughani
5 years
My friend @BrentonFargnoli backing next generation of healthcare entrepreneurs in NYC w/ @alley_corp
0
0
14
@JayRughani
Jay Rughani
2 years
Biodock's deep AI for bio image analysis is here. Out of beta and available to all.⚡️ Try it out if repetitive microscopy image analysis🔬 is slowing down your work. 🧬 @BiodockAI @MichaelLee04 @nurlybek_m
@MichaelLee04
Michael Lee
2 years
Today, we’re announcing that Biodock is coming out of beta. Biodock is the easiest way for biologists to create a remarkably accurate, AI pipeline for any bio images 🔬. It takes an afternoon, doesn’t require any code, and is incredibly accurate. A thread (1/8):
11
206
1K
1
1
14
@JayRughani
Jay Rughani
10 months
Welcome @AnjneyMidha ! Excited to work on (more👀) AI x Health & Bio opportunities together
@AnjneyMidha
Anjney Midha @ ICLR ‘24
10 months
1/ I’m joining @a16z !
106
32
800
0
0
15
@JayRughani
Jay Rughani
2 years
Science is getting funded in new ways! Great summary of emerging approaches by my colleague @heyjudka . DeSci is the most intriguing one on the list IMO 👀👀 #web3bio
@heyjudka
Judy Savitskaya
2 years
2021: year of the Modern Science Revolution? 👩‍🔬🧪 A cambrian explosion of new science funding models was driven by covid urgency, open science, frustration w/status quo. Most exciting: these models are built for translation & startup creation! 🧵of new science funding models:
13
266
1K
0
0
14
@JayRughani
Jay Rughani
2 years
Should be a good conversation 👀
@a16z
a16z
2 years
👋 Today on @Clubhouse : @Citadel CEO Ken Griffin joins @pmarca , @bhorowitz , @arampell and @AriannaSimpson for an unfettered conversation on finance, the future, and yes, the Constitution. Don’t miss it. 📅 12/1/21 ⏰ 5pm PT/8pm ET 🎧
Tweet media one
13
13
73
0
0
14
@JayRughani
Jay Rughani
3 years
We're lucky to have amazing guests on our two @a16z @Clubhouse shows during #HLTH2021 : Monday 8AM EST @nikillinit @cwhogg @singareddynm Tuesday 1:30PM EST @_KateRyder @amichellerees @portwi01
1
3
14